Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

MiaMed

M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of brain disorder medicines. The company provides research and development services for cyclin-dependent kinase-like 5 focused on treatment of brain disorders.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 641 Lexington Avenue
  • 15th Floor
  • New York, NY 10022
  • United States

MiaMed Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore MiaMed‘s full profile, request access.

Request full access to PitchBook

MiaMed Executive Team (1)

Name Title Board
Seat
Contact
Info
Michael Jasulavic Chief Executive Officer & President